The company said, “The Company is guiding to Q3 2025 Total revenues of $27 million to $30 million, which includes less than $100 thousand of COVID-19 testing revenues.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSUR:
- OraSure Technologies Reports 43% Revenue Decline in Q2 2025
- OraSure appoints Messing as Chief Commercial Officer
- OSUR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- OraSure received takeover bid from on Ron Zwanziger, Reuters reports
- OraSure bid between $3.50-$4.00 per share, Reuters says